MetaCap

National Health Investors Financial Ratios

NYSE: NHIReal EstateReal Estate Investment TrustsUSD

64.85+0.27 (+0.42%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

National Health Investors ratio analysis

National Health Investors earned a net margin of 37.9% in FY 2025, down from 41.2% a year earlier. Return on equity reached 9.3%, meaning National Health Investors generated 0.09 dollars of profit for every dollar of shareholders' equity. At the end of FY 2025, NHI traded at 25.4 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 16.7 to 35.3, with a median of 21.4.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

National Health Investors financial ratios (annual)

National Health Investors annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)25.4522.1117.8435.2823.5516.7122.0320.7819.4819.17
Price / sales9.599.057.588.408.799.2911.0410.8611.0611.65
Price / book2.372.221.931.841.742.042.342.302.332.39
Net margin37.9%41.2%42.4%23.9%37.4%55.6%50.4%52.4%57.2%61.0%
Free cash flow margin-15.3%14.9%42.2%62.7%53.7%34.7%1.2%20.4%8.0%-87.8%
Return on equity (ROE)9.3%10.1%10.8%5.2%7.4%12.2%10.7%11.1%12.1%12.5%
Return on assets (ROA)5.1%5.3%5.5%2.6%3.9%5.9%5.3%5.6%6.3%6.3%
Debt / equity—————————0.94
Revenue growth12.1%4.8%15.0%-6.9%-10.2%4.6%8.0%5.7%12.2%8.5%
EPS growth-3.5%0.0%111.5%-39.3%-41.1%12.8%0.0%-5.2%0.0%-2.0%

Related